Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-19
DOI
10.1038/s41379-019-0368-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
- (2019) Mingqi Han et al. JOURNAL OF CELL SCIENCE
- ATRX Promotes DNA Repair Synthesis and Sister Chromatid Exchange during Homologous Recombination
- (2018) Szilvia Juhász et al. MOLECULAR CELL
- Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
- (2018) Maheshi Udugama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical characteristics of Japanese patients with epithelioid hemangioendothelioma: a multicenter retrospective study
- (2018) Satoshi Shiba et al. BMC CANCER
- Metastatic epitheloid hemangioendothelioma (EHE): Role of systemic therapy and survival.
- (2017) A. Cioffi et al. JOURNAL OF CLINICAL ONCOLOGY
- Thoracic Epithelioid Malignant Vascular Tumors
- (2015) Todd Anderson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein
- (2015) M R Tanas et al. ONCOGENE
- Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases
- (2014) Uta Flucke et al. Diagnostic Pathology
- Surgical treatment and results of 62 patients with epithelioid hemangioendothelioma of bone
- (2014) Andrea Angelini et al. JOURNAL OF SURGICAL ONCOLOGY
- Malignant vascular tumors—an update
- (2014) Cristina Antonescu MODERN PATHOLOGY
- Anchored multiplex PCR for targeted next-generation sequencing
- (2014) Zongli Zheng et al. NATURE MEDICINE
- XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor
- (2014) KAIWU XU et al. Oncology Letters
- Sorafenib in patients with progressive epithelioid hemangioendothelioma
- (2013) Christine Chevreau et al. CANCER
- NovelYAP1-TFE3fusion defines a distinct subset of epithelioid hemangioendothelioma
- (2013) Cristina R. Antonescu et al. GENES CHROMOSOMES & CANCER
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
- (2012) M. Agulnik et al. ANNALS OF ONCOLOGY
- Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpoints
- (2012) Costantino Errani et al. Cancer Genetics
- Clinical Patterns and Outcome in Epithelioid Hemangioendothelioma With or Without Pulmonary Involvement
- (2011) Kenneth Lau et al. CHEST
- A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites
- (2011) Costantino Errani et al. GENES CHROMOSOMES & CANCER
- Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma
- (2011) M. R. Tanas et al. Science Translational Medicine
- Epithelioid Hemangioendothelioma of Soft Tissue: A Proposal for Risk Stratification Based on 49 Cases
- (2008) Andrea T. Deyrup et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More